Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 9/20 | 0.77 |
| ▸ | NPY2R | P49146 | 4/20 | 0.73 |
| ▸ | NPY4R | P50391 | 4/20 | 0.73 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.73 |
| ▸ | NPY1R | P25929 | 3/20 | 0.73 |
| ▸ | CALCA | P06881 | 2/20 | 0.69 |
| ▸ | GLP1R | P43220 | 3/20 | 0.68 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.66 |
| ▸ | CALCR | P30988 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29355231 | 0.90 | NPY1R (0.76) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| Water SCHEMBL29941416 | 0.90 | NPY1R (0.75) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| Acetic Acid SCHEMBL29399515 | 0.90 | NPY1R (0.75) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29437878 | 0.89 | CXCR4 (0.91) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29437879 | 0.89 | CXCR4 (0.91) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29416049 | 0.89 | NPY2R (0.75) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30692431 | 0.89 | NPY2R (0.75) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30527942 | 0.89 | NPY2R (0.75) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31060386 | 0.89 | CALCA (0.75) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29843747 | 0.88 | NPY1R (0.73) | CXCR4NPY2RNPY4RNPY5RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4554610-A1 | METHODS OF TREATING MALIGNANT GLIOMAS | Targepeutics, Inc. (US) | 2025-05-21 | — | — | EP | claimed |
| WO-2024015678-A1 | METHODS OF TREATING MALIGNANT GLIOMAS | TARGEPEUTICS, INC. (US) | 2024-01-18 | — | — | WO | claimed |